Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
34 Results for "
CCKB
" in MedChemExpress (MCE) Product Catalog:
Products (34)
34 Results for "CCKB" in MCE Product Catalog:
2
2 Cited Publications
Target:
Research Areas:
L-365260 is an orally active and selective antagonist of non-peptide gastrin and brain cholecystokinin receptor (CCK-B), with Kis of 1.9 nM and 2.0 nM, respectively. L-365260 interacts in a stereoselective and competitive manner with guinea pig stomach gastrin and brain CCK receptors. L-365260 can enhance Morphine analgesia and prevents Morphine tolerance .
2
2 Cited Publications
Target:
Research Areas:
YM022 is a highly potent, selective and orally active gastrin/cholecystokinin (CCK)-B receptor (CCK-BR) antagonist. YM022 shows the Ki values of 68 pM and 63 nM for CCK-B and CCK-A receptor, respectively . YM022 can inhibit gastrin-induced gastric acid secretion and histidine decarboxylase activation in vivo .
2
2 Cited Publications
Cat. No.: HY-106840A
Purity: 99.75%
Target:
Research Areas:
L-365260 hemihydrate is an orally active and selective antagonist of non-peptide gastrin and brain cholecystokinin receptor (CCK-B), with Kis of 1.9 nM and 2.0 nM, respectively. L-365260 hemihydrate interacts in a stereoselective and competitive manner with guinea pig stomach gastrin and brain CCK receptors .
1
Target:
Research Areas:
Cat. No.: HY-P1096
CAS No.: 130408-77-4
Target:
Research Areas:
Cat. No.: HY-U00360
CAS No.: 168161-71-5
Synonyms: (Rac)-Netazepide; (Rac)-YF 476; (Rac)-YM-220
Target:
Research Areas:
(Rac)-Sograzepide is an antagonist of cholecystokinin B (CCK-B) receptor, and has the potential of reducing the secretion of gastric acid.
Target:
Research Areas:
CCK-B Receptor Antagonist 2, compound 15b, is a potent and orally active Gastrin/CCK-B antagonist with an IC50 value of 0.43 nM. CCK-B Receptor Antagonist 2 also inhibits gastrin/CCK-A activity with an IC50 of 1.82 μM .
Cat. No.: HY-123434
CAS No.: 181941-32-2
Target:
Research Areas:
PD-149164 is a potent agonist of cholecystokinin B (CCK-B) receptor, with IC50 values of 0.083 nM and 75 nM in binding assay to CCK-B and CCK-A .
Cat. No.: HY-177508
Target:
Research Areas:
BC264 is a highly potent and selective CCK-B agonist that crosses the blood-brain barrier. BC264 increases dopamine in the nucleus accumbens and facilitates motivation and attention in rats .
Target:
Research Areas:
A-65186 is a CCK-A receptor antagonist with the activity of inhibiting CCK8-induced amylase secretion. A-65186 has high binding affinity for pancreatic CCK-A receptors, is more than 500 times more selective for CCK-A receptors than for CCK-B receptors, and can inhibit CCK8-induced amylase secretion.
Cat. No.: HY-106347
CAS No.: 201605-51-8
Synonyms: CR 2945
Target:
Research Areas:
Itriglumide (CR 2945) is an anthranilic acid derivative. Itriglumide is a potent and selective CCKB receptor antagonist, with an IC50 of 2.3 nM. Itriglumide antagonizes the response to gastrin in a dose-dependent manner with an IC50 of 5.9 nM. Itriglumide shows antisecretory and antiulcer activity .
Cat. No.: HY-129810
CAS No.: 130325-35-8
Synonyms: CAM 1028
Target:
Research Areas:
PD 135158 (CAM 1028) is a selective CCKB receptor antagonist with an IC50 of 2.8 nM against mouse cortex CCKB. PD 135158 shows anxiolytic activity .
Cat. No.: HY-U00360R
CAS No.: 168161-71-5
Synonyms: (Rac)-Netazepide (Standard); (Rac)-YF 476 (Standard); (Rac)-YM-220 (Standard)
Research Areas:
(Rac)-Sograzepide is an antagonist of cholecystokinin B (CCK-B) receptor, and has the potential of reducing the secretion of gastric acid.
Cat. No.: HY-19290
CAS No.: 171724-30-4
Target:
Research Areas:
S-0509 is a selective CCKB/gastrin receptor antagonist. S-0509 has a strong anti-secretion effect. S-0509 helps prevent the occurrence of duodenal ulcers .
Cat. No.: HY-111918
CAS No.: 127902-33-4
Target:
Research Areas:
A71378 is a selectivity CCK-A receptor agonist the IC50 values of 0.4 nM, 300 nM, and 1,200 nM for the pancreatic CCK-A, cortical CCK-B, and gastrin receptor, respectively. A71378 elicits pancreatic amylase secretion (EC50 = 0.16 nM) and ileal muscle contraction (EC50 = 3.7 nM) .
Cat. No.: HY-169139
CAS No.: 137795-35-8
Synonyms: CR-2194
Target:
Research Areas:
Spiroglumide (CR-2194) is a selective cholecystokinin B (CCKB) receptor antagonist .
Cat. No.: HY-A0261A
CAS No.: 57448-84-7
Synonyms: ICI-50123 meglumine
Target:
Research Areas:
Pentagastrin (ICI-50123) meglumine is a potent, selective Cholecystokinin B (CCKB) receptor agonist with an EC50 value of 11 nM. Pentagastrin meglumine enhances gastric mucosal defense mechanisms against acid and protects the gastric mucosa from experimental injury .
Cat. No.: HY-119127
CAS No.: 176915-07-4
Target:
Research Areas:
TP-680 is a cholecystokinin receptor antagonist. TP-680 binds 1510 times more strongly to rat pancreatic CCKA receptors (IC50=1.2 nM) than to rat brain CCKB receptors (IC50=1812.5 nM). TP-680 can be used in the study of gastrointestinal diseases .
Cat. No.: HY-RS02077
Target:
Research Areas:
CCKBR Human Pre-designed siRNA Set A contains three designed siRNAs for CCKBR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-118314
CAS No.: 156672-01-4
Synonyms: PD 144598
Target:
Research Areas:
CI-1015 is a potent CCK-B receptor antagonist.
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
